Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/125584
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBu, Pengcheng-
dc.contributor.authorWang, Lihua-
dc.contributor.authorChen, Kai-Yuan-
dc.contributor.authorRakhilin, Nikolai-
dc.contributor.authorSun, Jian-
dc.contributor.authorClosa, Adrià-
dc.contributor.authorTung, Kuei-Ling-
dc.contributor.authorKing, Sarah-
dc.contributor.authorKristine Varanko, Anastasia-
dc.contributor.authorXu, Yitian-
dc.contributor.authorHuan Chen, Joyce-
dc.contributor.authorZessin, Amelia S.-
dc.contributor.authorShealy, James-
dc.contributor.authorCummings, Bethany-
dc.contributor.authorHsu, David-
dc.contributor.authorLipkin, Steven M.-
dc.contributor.authorMoreno Aguado, Víctor-
dc.contributor.authorGümüş, Zeynep H.-
dc.contributor.authorShen, Xiling-
dc.date.accessioned2018-10-24T11:39:18Z-
dc.date.available2018-10-24T11:39:18Z-
dc.date.issued2015-04-15-
dc.identifier.issn2041-1723-
dc.identifier.urihttp://hdl.handle.net/2445/125584-
dc.description.abstractAs patient survival drops precipitously from early-stage cancers to late-stage and metastatic cancers, microRNAs that promote relapse and metastasis can serve as prognostic and predictive markers as well as therapeutic targets for chemoprevention. Here we show that miR-1269a promotes colorectal cancer (CRC) metastasis and forms a positive feedback loop with TGF-β signalling. miR-1269a is upregulated in late-stage CRCs, and long-term monitoring of 100 stage II CRC patients revealed that miR-1269a expression in their surgically removed primary tumours is strongly associated with risk of CRC relapse and metastasis. Consistent with clinical observations, miR-1269a significantly increases the ability of CRC cells to invade and metastasize in vivo. TGF-β activates miR-1269 via Sox4, while miR-1269a enhances TGF-β signalling by targeting Smad7 and HOXD10, hence forming a positive feedback loop. Our findings suggest that miR-1269a is a potential marker to inform adjuvant chemotherapy decisions for CRC patients and a potential therapeutic target to deter metastasis.-
dc.format.mimetypeapplication/pdf-
dc.language.isoeng-
dc.publisherNature Publishing Group-
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1038/ncomms7879.-
dc.relation.ispartofNature Communications, 2015, vol. 15, num. 6, p. 6879-
dc.relation.urihttps://doi.org/10.1038/ncomms7879.-
dc.rightscc-by (c) Bu, Pengcheng et al., 2015-
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es-
dc.sourceArticles publicats en revistes (Ciències Clíniques)-
dc.subject.classificationCàncer-
dc.subject.classificationQuimioteràpia del càncer-
dc.subject.classificationMetàstasi-
dc.subject.otherCancer-
dc.subject.otherCancer chemotherapy-
dc.subject.otherMetastasis-
dc.titlemiR-1269 promotes metastasis and forms a positive feedback loop with TGF-β-
dc.typeinfo:eu-repo/semantics/article-
dc.typeinfo:eu-repo/semantics/publishedVersion-
dc.identifier.idgrec660205-
dc.date.updated2018-10-24T11:39:23Z-
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess-
dc.identifier.pmid25872451-
Appears in Collections:Articles publicats en revistes (Ciències Clíniques)
Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

Files in This Item:
File Description SizeFormat 
660205.pdf3.16 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons